Anna Grebinyk
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Photodynamic Therapy Research Studies 8
- Radiation Therapy and Dosimetry 5
-
- Nanoparticle-Based Drug Delivery 7
- Co-authors
- Marcus Frohme (20 shared papers)Svitlana Prylutska (19 shared papers)Uwe Ritter (18 shared papers)Olga Matyshevska (14 shared papers)Yu. І. Prylutskyy (12 shared papers)Sergii Grebinyk (10 shared papers)Thomas Dandekar (8 shared papers)Vsevolod V. Cherepanov (3 shared papers)
In The Last Decade
Anna Grebinyk
26 papers receiving 445 citations
Peers
Comparison fields: 5 of 49
- Drug Discovery 3
- Biomaterials 86
- Organic Chemistry 168
- Biomedical Engineering 113
- Pulmonary and Respiratory Medicine 75
Countries citing papers authored by Anna Grebinyk
This map shows the geographic impact of Anna Grebinyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Grebinyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Grebinyk more than expected).
Fields of papers citing papers by Anna Grebinyk
This network shows the impact of papers produced by Anna Grebinyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Grebinyk. The network helps show where Anna Grebinyk may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Grebinyk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 72 | |
| 2 | 2018 | 55 | |
| 3 | 2019 | 45 | |
| 4 | 2019 | 40 | |
| 5 | 2019 | 40 | |
| 6 | 2019 | 31 | |
| 7 | 2022 | 23 | |
| 8 | 2021 | 22 | |
| 9 | 2018 | 18 | |
| 10 | 2022 | 15 | |
| 11 | 2024 | 15 | |
| 12 | 2017 | 13 | |
| 13 | 2023 | 12 | |
| 14 | 2013 | 10 | |
| 15 | 2021 | 7 | |
| 16 | 2023 | 6 | |
| 17 | 2025 | 6 | |
| 18 | 2021 | 3 | |
| 19 | 2024 | 3 | |
| 20 | 2025 | 3 |
About Anna Grebinyk
Anna Grebinyk is a scholar working on Pulmonary and Respiratory Medicine, Biomaterials, Organic Chemistry, Radiation and Biomedical Engineering, having authored 30 papers that have together received 448 indexed citations. Recurring topics across this work include Fullerene Chemistry and Applications (11 papers), Nanoplatforms for cancer theranostics (8 papers), Photodynamic Therapy Research Studies (8 papers), Nanoparticle-Based Drug Delivery (7 papers), Radiation Therapy and Dosimetry (5 papers), Particle Accelerators and Free-Electron Lasers (4 papers), Advanced Radiotherapy Techniques (4 papers) and Berberine and alkaloids research (2 papers). The work is most often cited by research in Drug Discovery (3 citations), Biomaterials (86 citations), Organic Chemistry (168 citations), Biomedical Engineering (113 citations) and Pulmonary and Respiratory Medicine (75 citations). Anna Grebinyk has collaborated with scholars based in Germany, Ukraine and China. Frequent co-authors include Marcus Frohme, Svitlana Prylutska, Uwe Ritter, Olga Matyshevska, Yu. І. Prylutskyy, Sergii Grebinyk, Thomas Dandekar, Vsevolod V. Cherepanov, Tymish Y. Ohulchanskyy and Volodymyr K. Rybalchenko. Their work appears in journals such as Nanoscale Research Letters, Pharmaceutics, International Journal of Molecular Sciences, Nanoscale Advances and Physica Medica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.